Skip to main content
PLOS One logoLink to PLOS One
. 2023 Nov 28;18(11):e0294427. doi: 10.1371/journal.pone.0294427

Ultraviolet-C light at 222 nm has a high disinfecting spectrum in environments contaminated by infectious pathogens, including SARS-CoV-2

Byeong-Min Song 1,#, Gun-Hee Lee 1,#, Hee-Jeong Han 1, Ju-Hee Yang 1, Eun-Gyeong Lee 1, Hyunji Gu 1, Ha-Kyeong Park 1, Kyunga Ryu 2, Jinwoo Kim 2, Sang-Min Kang 1,*, Dongseob Tark 1,*
Editor: Yong Sam Jung3
PMCID: PMC10684113  PMID: 38015931

Abstract

Ultraviolet light (UV) acts as a powerful disinfectant and can prevent contamination of personal hygiene from various contaminated environments. The 222-nm wavelength of UV-C has a highly effective sterilization activity and is safer than 275-nm UV-C. We investigated the irradiation efficacy of 222-nm UV-C against contaminating bacteria and viruses in liquid and fabric environments. We conducted colony-forming unit assays to determine the number of viable cells and a 50% tissue culture infectious dose assay to evaluate the virus titration. A minimum dose of 27 mJ/cm2 of 222-nm UV-C was required for >95% germicidal activity for gram-negative and -positive bacteria. A 25.1 mJ/cm2 dose could ensure >95% virucidal activity against low-pathogenic avian influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV-2). In addition, this energy dose of 222-nm UV-C effectively inactivated SARS-CoV-2 variants, Delta and Omicron. These results provide valuable information on the disinfection efficiency of 222-nm UV-C in bacterial and virus-contaminated environments and can also develop into a powerful tool for individual hygiene.

Introduction

Ultraviolet (UV) irradiation for commercial or medical use has been applied to prevent the transmission of infectious pathogens from contaminated food, water, surface, and air [1, 2]. UV devices have been developed according to their wavelength and application in community health. UV light is classified into UV-A (320−400 nm), UV-B (280−320 nm), and UV-C (200−280 nm) according to wavelength, and each UV light has different properties on sterilization efficacy and skin damage based on the emitted irradiation energy [3, 4]. Short-wavelength UV-C is recognized as a germicidal light and can be used to prevent localized infections for environmentally friendly cleaning due to not requiring any chemicals [5]. UV-C is effective in disinfecting areas contaminated with antibiotic-resistant pathogens [6]. The 254- and 275-nm UV-C are commercial germicidal wavelengths for disinfection. However, these can damage organic matter and the skin or eyes of humans and animals [7]. Consequently, 254- and 275-nm UV-C have only been used in manless environments and are recommended for covering an exposed area. Furthermore, the 222-nm UV-C termed far-UV-C (207−222 nm) demonstrates a similar inactivation effect against infectious pathogens to that of 254-nm UV-C and is less harmful to the skin and eyes in experimental animals [810]. This characteristic is caused by the different penetration following the UV-C wavelength, although this is similar to the absorption rate [11]. We chose the 222-nm UV-C to develop a small, portable sterilizer and a human gateway sterilizer that can be directly exposed to humans. The 222-nm wavelength was considered the safest and most effective in the UV-C irradiated human from a close distance. Recently, several studies reported that the aerosolized H1N1 influenza virus and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were inactivated by 222-nm UV-C [1214]. Both types of the virus produced a pandemic with fast transmission. Among the transmission routes when it spreads to liquid, such as coughing or sneezing, cotton fabrics, such as clothes, are contaminated. Here, we investigate the germicidal effect of 222-nm UV-C against gram-negative and -positive bacteria. Furthermore, we determined the virucidal efficacy of 222-nm UV-C against low-pathogenic avian influenza virus (LPAIV) and SARS-CoV-2 depending on exposure time, distance, and contaminated environments compared with that of 275-nm UV-C. UV-C irradiation at 222-nm effectively disinfects liquid and material contamination by key infectious pathogens, including SARS-CoV-2.

Materials and methods

Cell lines

African green monkey kidney (Vero E6) cells and Madin–Darby Canine kidney (MDCK) cells were cultured in Dulbecco’s modified Eagle minimum essential medium (DMEM, Gibco, USA) supplemented with 10% fetal bovine serum (FBS, Gibco, USA) and 10 U/mL penicillin/streptomycin (Gibco, USA) at 37°C in a 5% CO2 humidified atmosphere.

Bacteria and viruses

S. typhimurium (KVCC-BA0400600) and S. aureus (KVCC-BA200185) were provided by the Animal and Plant Quarantine Agency (APQA, South Korea). Bacteria were cultured aerobically at 37°C to an optical density at 600 nm (OD600) of 0.4–0.5 from single colony cultures in Luria–Bertani (LB) culture medium (BD Difco, USA). The number of colony-forming units was measured via serial dilution and viable colony counting. LPAIV H9N2 strain A/chicken/Korea/MS96/1996 (KVCC-VR1100013) was provided by the APQA. LPAIV was propagated through the allantoic cavity route in specific pathogen-free (SPF) embryonated chicken eggs. Inoculated SPF eggs were incubated for 4 days in a 37°C egg incubator. The allantoic fluid containing virus was harvested using a sterile syringe. SARS-CoV-2 Wuhan (BetaCoV/Korea/KCDC03/2020; NCCP 43326), Delta mutant (hCoV-19/Korea/KDCA210812/2021; NCCP 43390), and Omicron (hCoV-19/Korea/KDCA447321/2021; NCCP 43408) stains were provided by the Korea Disease Control and Prevention Agency (KDCA). SARS-CoV-2 was propagated in Vero E6 cells with DMEM supplemented with 2% FBS. The virus was harvested via the freezing-thawing method.

UV-C irradiation

UV-C equipment consisted of an unfiltered quart tube lamp with an irradiance of 4,360 mW/cm2 at a 10 mm/sec distance from the lamp. The 222-nm wavelength of UV-C was produced by excimer light technology. The UV-C equipment manufactured for the experiment was provided by the Biodech company in South Korea.

Biocidal activity test after UV-C irradiation

Bacteria were inoculated as single colonies in LB broth and incubated overnight in a shaking incubator at 37°C. Grown bacteria were seeded in fresh LB broth and incubated at 37°C until the OD600 reached 0.5. Bacteria were serially diluted 10−1 to 10−6 with LB broth and spread on an LB agar plate. LB agar plates were immediately irradiated with UV-C at differential dosages according to distance. After irradiation, the LB agar plates were incubated overnight at 37°C. The number of colonies was counted and calculated as a log10 CFU/ml.

Antiviral activity test of UV-C in liquid and fabric conditions

Antiviral test in liquid conditions: LPAIV and SARS-CoV-2 (both at 1 × 106 TCID50/mL) were placed on a sterile culture dish and then irradiated with UV-C at differential dosages according to distance. After irradiation, the viruses were serially diluted with TPCK-DMEM and serum-free DMEM and inoculated into MDCK or Vero E6 cells, respectively. The supernatant containing the virus was replaced with a fresh maintained medium at 1 h post-inoculation. MDCK cells were inoculated for 5 days, and the titration of LPAIV was measured using the hemagglutination (HA) assay. Cytopathic effects (CPEs) were observed in Vero E6 cells infected with SARS-CoV-2 for 3 or 4 days. The titration of SARS-CoV-2 was calculated using the tissue cultured infectious dose 50 (TCID50) method as previously described [15]. The antiviral test in fabric conditions: Sterile gauze (2 × 2 cm) was placed in a Petri dish and then LPAIV or SARS-CoV-2 (both at 1 × 107 TCID50/mL) were applied to individual pieces of gauze. Subsequently, the wet gauze was dried at 25°C for complete absorption (15 minute at class II Bio Safety Cabinet). The gauze containing the virus was irradiated with UV-C at differential dosages according to distance. After irradiation, the gauze was transferred to a 5-mL tube containing DMEM without fetal bovine serum and incubated for 1 h at room temperature to elute the virus from the gauze. The virus was serially diluted to inoculate the LPAVI into MDCK and SARS-CoV-2 into Vero E6 cells. Virus titration was calculated via the HA assay or by observing virus-induced cytopathic effects.

Immunofluorescence assay

Cells were fixed with a fixation buffer containing acetone and methanol in a 1:1 ratio. After 10 min, the cells were incubated with a blocking buffer containing 5% bovine serum albumin. Cells were labeled in blocking solution with rabbit polyclonal antibodies against the spike protein of SARS-CoV-2 (Sino Biologicals US Inc.). Cells were washed with PBS and then labeled with Alexa fluor 488-conjugated anti-rabbit IgG (Cell Signaling Technology, USA) in PBS. Nuclei were stained with 4’, 6-diamidino-2-phenylindole (Cell Signaling Technology). Immunofluorescence signals were observed using a CELENA® S digital imaging system (Logos Biosystems, South Korea). The fluorescence intensity quantification was analyzed using HALO image analysis software (HALO v34.2986.185).

RNA isolation and real-time PCR

Total cellular RNA was extracted from cells infected with SARS-CoV-2 using TRIzol Reagent (Invitrogen, USA). cDNA was synthesized using the CellScriptTM cDNA master mix (Cell Signaling Technology, USA). The NSP2 and N genes of SARS-CoV-2 were amplified from the synthesized cDNA using IQ SYBR green Supermix (Bio-Rad, South Korea). The described sets of primers were used: NSP2 forward primer, 5’-GTA TTG TTA TAG CGG CCT TCT G-3’; NSP2 reverse primer, 5’-ATG CAT TTG CAT CAG AGG CTG C-3’; N gene forward primer, 5’-TAA TCA GAC AAG GAA CTG ATT A-3’; N gene reverse primer, 5’-CGA AGG TGT GAC TTC CAT G-3’. Thermal cycling was performed as follows: initial denaturation at 95°C for 3 min, 40 cycles of denaturation at 95°C for 10 sec, and annealing/extension at 55°C for 30 sec.

Results

Germicidal effect of 222-nm UV-C light against gram-negative and -positive bacteria

UV-C equipment manufactured for emittance of UV light at 222 and 275 nm was received from Biodech in South Korea. The energy dosage of both UV-C equipment’s over a distance and exposure time is described in Table 1. The germicidal efficacy test of both UV-C wavelengths against two different bacterial species was performed. Briefly, Salmonella typhimurium (gram negative) and Staphylococcus aureus (gram positive) were cultured in suspension and then spread on an LB agar plate without antibiotics. Subsequently, the bacterial lawn was irradiated with either 222- or 275-nm UV-C at various irradiation doses over different distances. The number of viable bacteria was then counted by colony formation. We then determined that the optimum distance for 222-nm UV-C efficient germicidal activity. The disinfecting activity of UV-C is affected by irradiation time and distance from the lamp. [16, 17]. At 200-mm distance, irradiation for 5 s (85 mJ/cm2) of 275-nm UV-C reduced the bacterial number by 97% for S. typhimurium and 98.2% for S. aureus. Furthermore, both species were undetectable following irradiation for 20 s (340 mJ/cm2) with 275-nm UV-C (Fig 1A). Irradiation for 60 s (21.12 mJ/cm2) of 222-nm UV-C reduced the bacterial number by 82.27% for S. typhimurium; whereas the number of S. aureus was reduced 99.5% when irradiated for 30 sec (10.56 mJ/cm2), and was undetectable when irradiated for 60 sec (21.12 mJ/cm2) with 222-nm UV-C (Fig 1A and S1 Table). At 100-mm distance, both bacteria species were undetectable following 275-nm UV-C irradiation for 5 s (520 mJ/cm2). By contrast, 20 s (18 mJ/cm2) of 222-nm UV-C irradiation was required to reduce bacterial numbers to undetectable levels with S. aureus and 60 sec (54 mJ/cm2) were required for the same effect on S. typhimurium numbers (Fig 1B and S1 Table). Although the germicidal efficiency of 222-nm UV-C was lower than 275-nm UV-C at the same exposure time, it was safer and had a potent germicidal effect that was dosage-dependent in both bacterial species. In addition, we found that S. aureus was more sensitive than S. typhimurium to irradiation of 222-nm UV-C at the same distance and time.

Table 1. The energy dosage of UV-C equipment over a distance and exposure times.

Equipment (UV-C) Distance (mm) Dosage/sec (mJ/cm 2 ) Dosage / Exposure time (second)
5 10 20 30 60
222 nm 50 2.510 12.55 25.1 50.2 75.3 150.6
100 0.900 4.5 9 18 27 54
200 0.352 1.76 3.52 7.04 10.56 21.12
275 nm 50 275 1375 2750 5500 8250 16500
100 104 520 1040 2080 3120 6240
200 17 85 170 340 510 1020

Fig 1. Alteration in the germicidal activity of UV-C against bacteria at different irradiation distances and times.

Fig 1

The reduction rate of S. typhimurium and S. aureus by UV-C irradiation at distances of 200 mm (A) and 100 mm (B) during the indicated times. Representative data show the mean and standard deviation by three independent experiments. Two-way ANOVA was performed, followed by Tukey’s multiple comparison tests. Statistical significance is induced by asterisks (n = 3, **P < 0.01, ***p < 0.001, ****p < 0.0001).

Virucidal activity of 222-nm UV-C on LPAIV-contaminated environments

Several studies have been conducted since the development of UV-C (including at 222 nm) that reported the antiviral potential against various viruses [1820]. Next, we evaluated the virucidal activity of 222-nm UV-C using two different contaminated conditions with LPAIV and SARS-CoV-2. First, virus-containing supernatant was placed on a sterile tissue culture dish and then directly irradiated with UV-C at various times and distances (liquid environment). Second, UV-C irradiation was also assessed under various conditions after absorbing the supernatant onto gauze (fabric environment). At 200-mm distance, irradiation for 10, 30, and 60 s (170, 510, and 1,020 mJ/cm2, respectively) of 275-nm UV-C produced a reduction of 2.9, 4.1, and 4.1 log10 (99.9%, 99.99%, and 99.99% reduction rate, respectively) of liquid-LPAIV. Irradiation for 10, 30, and 60 s (3.52, 10.56, and 21.12 mJ/cm2, respectively) of 222-nm UV-C produced a reduction of 1.1, 1.3, and 1.6 log10 (91.1%, 94.8%, and 97.5% reduction rate, respectively) of liquid-LPAIV (Fig 2A). The fabric-LPAIV was reduced by 1.5, 1.9, and 3.1 log10 (97%, 98.8%, and 99.92% reduction rate, respectively) and by 0.63, 0.8, and 1 log10 (76.6%, 84.2%, 90% reduction rate, respectively) after irradiation of 275-nm and 222-nm UV-C in same distance and times (Fig 2B). The liquid- and fabric-LPAIV were inactivated by 222-nm UV-C irradiation for 10, 30, and 60 s with a 1.6, 2.3, and 3.0 log10 reduction, respectively, in liquid (97.2%, 99.5%, and 99.9% reduction rate, respectively) and a 1.5, 2.3, and 2.6 log10 reduction, respectively, in fabric (96.8%, 99.5%, and 99.8% reduction rate, respectively) at 50-mm distance (Fig 2C and 2D). Irradiation at 50-mm with 275-nm UV-C irradiation for 10 s completely inactivated LPAIV in liquid and fabric (Fig 2B and 2C, left). These results demonstrated that 222-nm UV-C requires at least 25.1 mJ/cm2 energy to show >95% virucidal activity against LPAIV. We summarized the inactivated LPAIV rate by irradiation using 222-nm and 275-nm UV-C with 200- and 50-mm distances in liquid- and fabric-contaminated conditions (Fig 2E and 2F).

Fig 2. Inactivation of LPAIV by UV-C irradiation in two contaminated environmental conditions following irradiation at different distances and times.

Fig 2

The reduction rate of liquid- and fabric-LPAIV upon UV-C irradiation at distances of 200 mm (A and B) and 50 mm (C and D) during the indicated times. Inactivation rate of liquid- and fabric-LPAIV in panels (E) and (F). Representative data show the mean and standard deviation by three independent experiments. Two-way ANOVA with Tukey’s multiple comparison tests was used to determine the significance (n = 3, ****p < 0.0001).

Virucidal activity of 222-nm UV-C on SARS-CoV-2-contaminated environments

We assess the virucidal activity of 222-nm UV-C against SARS-CoV-2 in liquid- and fabric-contaminated conditions. This was first conducted using the fixed 50-mm distance, which was effective in a short time against LPAIV. The SARS-CoV-2 were markedly inactivated by 222-nm UV-C irradiation at 10 and 30 s in liquid with a respective 2.1 and 4.4 log10 reduction (99.1% and 99.99% reduction rate, respectively) and in fabric with a respective 2.8 and 4.72 log10 reduction (99.9% and 99.99% reduction rate, respectively) that decreased to undetectable at 60 s in both conditions at the 50-mm distance. In contrast, irradiation for 10 s of 275-nm UV-C completely inactivated liquid- and fabric-SARS-CoV-2 (Fig 3A and 3B). We showed that SARS-CoV-2 was 99% inactivated by 222- and 275 nm UV-C irradiation for only 10 s with 50-mm distance in both liquid- and fabric-contaminated condition (Fig 3C).

Fig 3. Antiviral effect of UV-C against SARS-CoV-2 in two contaminated environmental conditions.

Fig 3

(A) Liquid- and (B) fabric-contaminated with infectious SARS-CoV-2 was irradiated with by UV-C at a distance of 50 mm during the indicated times. (C) Comparison of SARS-CoV-2 inactivation rate using 222- and 275-nm UV-C between liquid- and fabric-contaminated environments at 50-mm distance. Represent data show the mean and standard deviation by three independent experiments. Two-way ANOVA with Tukey’s multiple comparison tests was used to calculate the significance (n = 3, ****p < 0.0001).

Second, we investigated the infectivity of liquid-SARS-CoV-2 by measuring the expression of two viral genes: nonstructural protein 2 (NSP2) and nucleocapsid (N). When irradiated with 222-nm UV-C for 10 s at 50-mm distance, which corresponding to an energy of 25.1 mJ/cm2, the viral RNA was reduced to an undetectable level in liquid-SARS-CoV-2-infected Vero E6 cells (Fig 4A). Moreover, we determined the effect of 222-nm UV-C against liquid-SARS-CoV-2 infectivity using an immunofluorescence assay. The expression of the viral spike glycoprotein (S protein) in the liquid-SARS-CoV-2 was reduced by approximately 90% during irradiation at 25.1 mJ/cm2, as indicated by a reduction in green fluorescence (Fig 4B). These results indicate that SARS-CoV-2 is highly sensitive to UV-C light, and inactivation can be rapidly achieved using 222-nm UV-C.

Fig 4. Evaluation of disinfection activity of 222-nm UV-C against SARS-CoV-2.

Fig 4

(A) SARS-CoV-2 was irradiated by 222-nm UV-C during the indicated times at a 50-mm distance before infection into Vero E6 cells. At 24-h post-infection, total RNA was extracted from cells infected with SARS-CoV-2. Expression of the NSP2 and N genes of SARS-CoV-2 were quantified via qRT-PCR using specific primer sets. (B) Vero E6 cells infected with SARS-CoV-2 labeled with spike protein (GFP) were detected using the CELENA® S digital imaging system. The quantification of the fluorescence intensity was analyzed by GFP/DAPI using HALO image analysis software. One-way ANOVA with Tukey’s multiple comparison tests was used to calculate the significance (n = 3, ****p < 0.0001).

SARS-CoV-2 variants of concern (VOCs) have been reported [21, 22] and contribute to perpetuating the pandemic. Therefore, we next established the effect of 222-nm UV-C against SARS-CoV-2 variants such as B1.617.2 (Delta) and BA.1 (Omicron). The infectivity of liquid-SARS-CoV-2 variants was measured by immunostaining of S protein after 222-nm UV-C irradiation for 10, 30, and 60 s at 50-mm distance. Irradiation for 10 s (25.1 mJ/cm2) with 222-nm UV-C reduced the level of fluorescence of S protein by 58.05% (Delta) and 89.78% (Omicron) compared with that in unirradiated SARS-CoV-2 variants. Irradiation for 30 s (75.3 mJ/cm2) reduced fluorescence by 98.4% (Delta) and 95.58% (Omicron); 60 s (150.6 mJ/cm2) of irradiation completely inactivated both liquid-SARS-CoV-2 variants (Fig 5A). Finally, we analyzed the levels of viral proteins in Vero E6 cells infected with the irradiated liquid-SARS-CoV-2 variants to confirm virus sterilization by 222-nm UV-C. The levels of N and S protein levels of SARS-CoV-2 were significantly decreased following irradiation with 222-nm UV-C (Fig 5B). Therefore, SARS-CoV-2 variants were quickly inactivated and completely lost infectivity following irradiation with 222-nm UV-C at 75.3 mJ/cm2 of 222-nm UV-C.

Fig 5. Disinfecting capacity of 222-nm UV-C against SARS-CoV-2 variants.

Fig 5

(A) B1.617.2 (Delta) and BA.1 (Omicron) variants were irradiated with 222-nm UV-C during the indicated times at a 50-mm distance before infection into Vero E6 cells. At 24-h post-infection, cells were labeled with SARS-CoV-2 spike (S) protein and then detected using the CELENA® S digital imaging system. The quantification of the fluorescence intensity was analyzed by GFP/DAPI using HALO image analysis software. One-way ANOVA was performed, followed by Tukey’s multiple comparison tests and calculation of the significance (n = 3, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). (B) N and S proteins of SARS-CoV-2 were detected in the cell lysates using western blotting at the indicated irradiation times. Relative S and N protein expression was normalized by that of GAPDH using Image J software (version 1.53k, http://imagej.nih.gov/ij/).

Discussion

The mechanism of UV-induced sterilization is reported to induce genetic damage in DNA/RNA strands of microbial cells or viruses. The production of UV-induced cyclobutene pyrimidine dimers causes the deformation of DNA and RNA molecules, which may induce the inactivation of cell metabolism [23]. In addition, UV irradiation generates free radicals and reactive oxygen species (ROS) with 30% penetration. The UV-induced ROS triggers several cytotoxic processes disrupting membrane integrity, DNA damage, and inactivating cellular enzymes [24, 25]. However, this UV-induced damage is affected by various UV wavelengths. In particular, UV-C light is less damaging as it cannot penetrate as deeply into tissue layers as UV-B can [26]. We considered that UV-C-induced cell damage was due dependent on the components of the cell wall and membrane. In this study, we assessed two categories of bacteria: gram-positive contains a thick peptidoglycan cell layer but no outer lipid membrane, whereas gram-negative contains a thin peptidoglycan layer and outer lipid membrane. Microorganisms have been reported to have different sensitivities against 222-nm UV-C [27]. Our results show that the irradiation of 275-nm UV-C within 10 s (<170 mJ/cm2) was sufficient to inactivate bacteria, regardless of cell membrane compositions and distance from a lamp. In contrast, at 100-mm distance, irradiation with >27 mJ/cm2 energy of 222-nm UV-C was required to inactivate S. typhimurium, and at least 9 mJ/cm2 energy was needed to inactivate S. aureus (Fig 1). We considered that the 222-nm UV-C easily penetrates the peptidoglycan layer, whereas it is inhibited by a lipid membrane containing multiunit saccharides and proteins. The germicidal activity of 222-nm UV-C is required for suitable penetration energy based on the irradiation time and distance from a lamp against different microorganisms. The virucidal activity of 222-nm UV-C, like that of 254-nm, against various viruses, including DNA and RNA forms and enveloped and nonenveloped forms, has been reported [2831]. However, the 222-nm UV-C mechanism for disinfecting viruses is poorly understood. The 222-nm UV-C light has minimal penetration because this light is absorbed strongly by several proteins and biomolecules compared with 254-nm UV-C [32]; however, the limited penetration of 222-nm UV-C is sufficient to traverse viruses <1 μm in size. Thus, 222-nm UV-C has virucidal activity without producing adverse side effects [33, 34]. Herein, we assessed the virucidal activity of 222-nm UV-C against potential pandemic viruses such as avian influenza and SARS-CoV-2 by testing their persistence in fabric and in liquid-contaminated environments. The avian influenza virus belongs to the type A influenza virus and is divided into high- or low-pathogenic avian influenza viruses based on the pathogenicity. Although LPAIV generally has mild symptoms, it can be transmitted to humans, causing severe illness [35]. The human-transmitted H7N9 strain as LPAIV caused a worldwide outbreak between early 2013 and 2017 [36]. UV-C has since been recognized as a valuable tool for reducing the risk of viral-contaminated environment exposure in biosecurity programs [3739]. We tested the virucidal activity of UV-C against LPAIV in two different virus-contaminated conditions: liquid and fabric. At 200-mm distance, the 222-nm UV-C was ineffective compared with 275-nm UV-C irradiation in both contaminated conditions, even energy dosages up to 21.12 mJ/cm2. Although the virucidal activity was lower in the fiber conditions than in the liquid condition, the antiviral activity of both UV-Cs wavelengths was improved by increasing the irradiation dose by adjusting the distance (Fig 2). These differences between liquid- and fabric-LPAIV may be due to the penetration rates of UV-C based on contamination conditions. We believed that it would not be easy to target the absorbed virus in the fabric conditions because the penetration of UV-C light is disturbed by the fiber layer. Since the WHO declared the coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, there has been a continuous threat to public health [40]. SARS-CoV-2 is transmitted directly from person to person through droplets and indirectly via contaminated environments [41]. During the COVID-19 pandemic, UV disinfection, which can disinfect places or objects contaminated by SARS-CoV-2, attracted attention and many products have been developed [42]. The comprehensive use of UV-C devices is expected to limit SARS-CoV-2 spread in hospitals and public healthcare facilities. Many experimental studies strongly support that UV-C irradiation rapidly inactivates infectious SARS-CoV-2 [43, 44]. Our results confirmed that 222-nm UV-C at an energy of 25.1 mJ/cm2 efficiently inactivated SARS-CoV-2 (including recent VOC) in liquid and fabric environments. The virucidal activity of UV-C affects the viral genome and thus can occur regardless of which SARS-CoV-2 variant is present. Typically, the reproduction of RNA viruses is prone to error because of the lack of proofreading machinery. The error rates may be close to those that kill the virus. For this reason, genetic damage to a single-stranded viral genome by UV-C irradiation is thought to be more lethal. Therefore, 222-nm UV-C can be applied in public places such as airports, hospitals and medical facilities and is effective and safe. In conclusion, we investigated the disinfection efficacy of 222nm UV-C against both gram-negative and -positive bacteria and two potential pandemic viruses through two different methods. Our results suggest that 222-nm UV-C is a useful disinfection tool against various pathogens and should be further investigated in studies on safety and effectiveness for practical applications.

Supporting information

S1 Table. Survival rate of cell numbers by irradiated UV-C with several optical dosages.

(PPTX)

S1 Raw image

(PDF)

Acknowledgments

Information on the UV-C from the Biodech company used in this study is provided in the supporting information. The authors thank the staff from the Biosafety-Level 3 facility (Korea Zoonosis Research Institute, Jeonbuk National University). All experiment raw data included in this study could be available upon request by containing the corresponding author Sang-Min Kang via email: sangminkang@jbnu.ac.kr

Data Availability

we provide the original uncropped and unadjusted image and blot results reported in a "original figure raw image" file.

Funding Statement

This research was supported by the grant of the Korea Health Industry Development Institute (KHIDI, HI22C1637) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1C1C2005307 and 2017R1A6A1A03015876). Sang-Min Kang received a research fund, HI22C1637, from KHIDI and contributed to conceptualizing research, data curation, methodology, supervision, manuscript review, and editing. Gun-Hee Lee received a research fund, 2021R1C1C2005307, from NRF and was involved in Formal analysis, methodology, validation, and manuscript writing. Dongseob Tark received a research fund, 2017R1A6A1A03015876, from NRF and was involved in conceptualization, supervision, validation, and manuscript review.

References

  • 1.Anderson DJ, Gergen MF, Smathers E, Sexton DJ, Chen LF, Weber DJ, et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol. 2013;34(5):466–471. doi: 10.1086/670215 ; PubMed Central PMCID: PMC3703853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chang JC, Ossoff SF, Lobe DC, Dorfman MH, Dumais CM, Qualls RG, et al. UV inactivation of pathogenic and indicator microorganisms. Appl Environ Microbiol. 1985;49(6):1361–1365. doi: 10.1128/aem.49.6.1361-1365.1985 ; PubMed Central PMCID: PMC241729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mohania D, Chandel S, Kumar P, Verma V, Digvijay K, Tripathi D, et al. Ultraviolet radiations: skin defense-damage mechanism. Adv Exp Med Biol. 2017;996:71–87. doi: 10.1007/978-3-319-56017-5_7 . [DOI] [PubMed] [Google Scholar]
  • 4.Rathod DG, Muneer H, Masood S. Phototherapy. Treasure Island (FL): StatPearls Publishing; 2022. [PubMed] [Google Scholar]
  • 5.She RC, Chen D, Pak P, Armani DK, Schubert A, Armani AM. Lightweight UV-C disinfection system. Biomed Opt Express. 2020;11(8):4326–4332. doi: 10.1364/BOE.395659 ; PubMed Central PMCID: PMC7449718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Yang JH, Wu UI, Tai HM, Sheng WH. Effectiveness of an ultraviolet-C disinfection system for reduction of healthcare-associated pathogens. J Microbiol Immunol Infect. 2019;52(3):487–493. doi: 10.1016/j.jmii.2017.08.017 . [DOI] [PubMed] [Google Scholar]
  • 7.Ploydaeng M, Rajatanavin N, Rattanakaemakorn P. UV-C light: A powerful technique for inactivating microorganisms and the related side effects to the skin. Photodermatol Photoimmunol Photomed. 2021;37(1):12–19. doi: 10.1111/phpp.12605 . [DOI] [PubMed] [Google Scholar]
  • 8.Narita K, Asano K, Morimoto Y, Igarashi T, Nakane A. Chronic irradiation with 222-nm UVC light induces neither DNA damage nor epidermal lesions in mouse skin, even at high doses. PLOS ONE. 2018;13(7):e0201259. doi: 10.1371/journal.pone.0201259 ; PubMed Central PMCID: PMC6059456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ponnaiya B, Buonanno M, Welch D, Shuryak I, Randers-Pehrson G, Brenner DJ. Far-UVC light prevents MRSA infection of superficial wounds in vivo. PLOS ONE. 2018;13(2):e0192053. doi: 10.1371/journal.pone.0192053 ; PubMed Central PMCID: PMC5821446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yamano N, Kunisada M, Kaidzu S, Sugihara K, Nishiaki-Sawada A, Ohashi H, et al. Long-term effects of 222-nm ultraviolet radiation C sterilizing lamps on mice susceptible to ultraviolet radiation. Photochem Photobiol. 2020;96(4):853–862. doi: 10.1111/php.13269 ; PubMed Central PMCID: PMC7497027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kaidzu S, Sugihara K, Sasaki M, Nishiaki A, Igarashi T, Tanito M. Evaluation of acute corneal damage induced by 222-nm and 254-nm ultraviolet light in Sprague-Dawley rats. Free Radic Res. 2019;53(6):611–617. doi: 10.1080/10715762.2019.1603378 . [DOI] [PubMed] [Google Scholar]
  • 12.Kitagawa H, Nomura T, Nazmul T, Omori K, Shigemoto N, Sakaguchi T, et al. Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination. Am J Infect Control. 2021;49(3):299–301. doi: 10.1016/j.ajic.2020.08.022 ; PubMed Central PMCID: PMC7473342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Welch D, Buonanno M, Grilj V, Shuryak I, Crickmore C, Bigelow AW, et al. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Sci Rep. 2018;8(1):2752. doi: 10.1038/s41598-018-21058-w ; PubMed Central PMCID: PMC5807439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Buonanno M, Welch D, Shuryak I, Brenner DJ. Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Sci Rep. 2020;10(1):10285. doi: 10.1038/s41598-020-67211-2 ; PubMed Central PMCID: PMC7314750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493–497. 10.1093/oxfordjournals.aje.a118408. [DOI] [Google Scholar]
  • 16.De Groot T, Chowdhary A, Meis JF, Voss A. Killing of Candida auris by UV-C: importance of exposure time and distance. Mycoses. 2019;62(5):408–412. doi: 10.1111/myc.12903 ; PubMed Central PMCID: PMC6850319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dai T, Vrahas MS, Murray CK, Hamblin MR. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther. 2012;10(2):185–195. doi: 10.1586/eri.11.166 ; PubMed Central PMCID: PMC3292282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pendyala B, Patras A, Pokharel B, D’Souza D. Genomic modeling as an approach to identify surrogates for use in experimental validation of SARS-CoV-2 and HuNoV inactivation by UV-C treatment. Front Microbiol. 2020;11:572331. doi: 10.3389/fmicb.2020.572331 ; PubMed Central PMCID: PMC7550400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Araud E, Fuzawa M, Shisler JL, Li J, Nguyen TH. UV inactivation of rotavirus and tulane virus targets different components of the virions. Appl Environ Microbiol. 2020;86(4):e02436–19. doi: 10.1128/AEM.02436-19 ; PubMed Central PMCID: PMC6997730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nishisaka-Nonaka R, Mawatari K, Yamamoto T, Kojima M, Shimohata T, Uebanso T, et al. Irradiation by ultraviolet light-emitting diodes inactivates influenza A viruses by inhibiting replication and transcription of viral RNA in host cells. J Photochem Photobiol B. 2018;189:193–200. doi: 10.1016/j.jphotobiol.2018.10.017 . [DOI] [PubMed] [Google Scholar]
  • 21.Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J. 2021;62(11):961–968. doi: 10.3349/ymj.2021.62.11.961 ; PubMed Central PMCID: PMC8542474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.SARS-CoV-2 variants classifications and definitions. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications. [Google Scholar]
  • 23.Yin R, Dai T, Avci P, Jorge AES, de Melo WCMA, Vecchio D, et al. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol. 2013;13(5):731–762. doi: 10.1016/j.coph.2013.08.009 ; PubMed Central PMCID: PMC3831650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ijiri S, Kobayashi A, Sugiyama K, Tseng SCG. Measurement of light transmittance of cryopreserved human amniotic membrane. Cornea. 2006;25(9):1080–1083. doi: 10.1097/01.ico.0000230495.14896.72 [DOI] [PubMed] [Google Scholar]
  • 25.Santos AL, Gomes NCM, Henriques I, Almeida A, Correia A, Cunha Â. Contribution of reactive oxygen species to UV-B-induced damage in bacteria. J Photochem Photobiol B. 2012;117:40–46. doi: 10.1016/j.jphotobiol.2012.08.016 . [DOI] [PubMed] [Google Scholar]
  • 26.Reed NG. The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep. 2010;125(1):15–27. doi: 10.1177/003335491012500105 ; PubMed Central PMCID: PMC2789813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Narita K, Asano K, Naito K, Ohashi H, Sasaki M, Morimoto Y, et al. 222-nm UVC inactivates a wide spectrum of microbial pathogens. J Hosp Infect. 2020;S0195-6701:30129–30128. doi: 10.1016/j.jhin.2020.03.030 . [DOI] [PubMed] [Google Scholar]
  • 28.Tseng CC, Li CS. Inactivation of virus-containing aerosols by ultraviolet germicidal irradiation. Aerosol SIC Technol. 2005;39(12):1136–1142. 10.1080/02786820500428575. [DOI] [Google Scholar]
  • 29.Pinon A, Vialette M. Survival of viruses in water. Intervirology. 2018;61(5):214–222. doi: 10.1159/000484899 . [DOI] [PubMed] [Google Scholar]
  • 30.Oh C, Sun PP, Araud E, Nguyen TH. Mechanism and efficacy of virus inactivation by a microplasma UV lamp generating monochromatic UV irradiation at 222 nm. Water Res. 2020;186:116386. doi: 10.1016/j.watres.2020.116386 . [DOI] [PubMed] [Google Scholar]
  • 31.Horton L, Torres AE, Narla S, Lyons AB, Kohli I, Gelfand JM, et al. Spectrum of virucidal activity from ultraviolet to infrared radiation. Photochem Photobiol Sci. 2020;19(10):1262–1270. doi: 10.1039/d0pp00221f ; PubMed Central PMCID: PMC8047562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Goldfarb AR, Saidel LJ. Ultraviolet absorption spectra of proteins. Science 1951;114(2954):156–157. doi: 10.1126/science.114.2954.156 . [DOI] [PubMed] [Google Scholar]
  • 33.Coohill TP. Virus-cell interactions as probes for vacuum-ultraviolet radiation damage and repair. Photochem Photobiol 1986;44(3):359–363. doi: 10.1111/j.1751-1097.1986.tb04676.x . [DOI] [PubMed] [Google Scholar]
  • 34.Buonanno M, Ponnaiya B, Welch D, Stanislauskas M, Randers-Pehrson G, Smilenov L, et al. Germicidal efficacy and mammalian skin safety of 222-nm UV light. Radiat Res. 2017;187(4):483–491. doi: 10.1667/RR0010CC.1 ; PubMed Central PMCID: PMC5552051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Li YT, Linster M, Mendenhall IH, Su YCF, Smith GJD. Avian influenza viruses in humans: lessons from past outbreaks. Br Med Bull. 2019;132(1):81–95. doi: 10.1093/bmb/ldz036 ; PubMed Central PMCID: PMC6992886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.World Health Organization. Human infection with avian influenza A (H7N9) virus-China, Disease outbreak news. 2017. Jan 17. In: World Health Organization [Internet]. Geneva. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/26-october-2017-ah7n9-china-en/. [Google Scholar]
  • 37.McDevitt JJ, Rudnick SN, Radonovich LJ. Aerosol susceptibility of influenza virus to UV-C light. Appl Environ Microbiol. 2012;78(6):1666–1669. doi: 10.1128/AEM.06960-11 ; PubMed Central PMCID: PMC3298127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bedell K, Buchaklian AH, Perlman S. Efficacy of an automated multiple emitter whole-room ultraviolet-C disinfection system against coronaviruses MHV and MERS-CoV-2. Infect Control Hosp Epidemiol. 2016;37(5):598–599. doi: 10.1017/ice.2015.348 ; PubMed Central PMCID: PMC5369231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Napolitano NA, Mahapatra T, Tang W. The effectiveness of UV-C radiation for facility-wide environmental disinfection to reduce health care-acquired infections. Am J Infect Control. 2015;43(12):1342–1346. doi: 10.1016/j.ajic.2015.07.006 . [DOI] [PubMed] [Google Scholar]
  • 40.World Health Organization. Coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Google Scholar]
  • 41.Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi: 10.1056/NEJMc2004973 ; PubMed Central PMCID: PMC7121658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shining a light on COVID-19. Nat Photonics. 2020;14(6):337. 10.1038/s41566-020-0650-9. [DOI] [Google Scholar]
  • 43.Heßling M, Hönes K, Vatter P, Lingenfelder C. Ultraviolet irradiation doses for coronavirus inactivation–review and analysis of coronavirus photoinactivation studies. GMS Hyg Infect Control. 2020;15:Doc08. doi: 10.3205/dgkh000343 ; PubMed Central PMCID: PMC7273323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Inagaki H, Saito A, Sugiyama H, Okabayashi T, Fujimoto S. Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation. Emerg Microbes Infect. 2020;9(1):1744–1747. doi: 10.1080/22221751.2020.1796529 ; PubMed Central PMCID: PMC7473214. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Yong Sam Jung

3 Oct 2023

PONE-D-23-28082Ultraviolet-C light at 222 nm has a high disinfecting spectrum in environments contaminated by infectious pathogens, including SARS-CoV-2PLOS ONE

Dear Dr. Kang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yong Sam Jung, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following: 

● The name of the colleague or the details of the professional service that edited your manuscript

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

4. Thank you for stating the following financial disclosure: 

   "This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1C1C2005307 and 2017R1A6A1A03015876) and supported by the grant of the Korea Health Industry Development Institute (KHIDI, HI22C1637). 

S.K. received research funding, HI22C1637, from KHIDI,  G.L., and D.T. received 2021R1C1C2005307 and 2017R1A6A1A03015876 from NRF. "

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

7. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. 

  

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

8. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

9. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

10. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

When revising your manuscript, please consider all issues mentioned in the reviewers' comments carefully: please outline every change made in response to their comments and provide suitable rebuttals for any comments not addressed. Please note that your revised submission may need to be re-reviewed. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript, authors investigated the effect of UVC at 222nm for disinfection of pathogens, particularly SARS-Cov-2, comparing with 275nm UVC. Authors clearly showed that the 222nm UVC exerts the the germicidal and virucidal activity against SARS-cov-2 and couple of bacteria in various contaminating conditions (liquid, fabric) and can effectively inactivates SARS-cov-2 variants such as Delta and Omicron. Considering the significance of pandemic situation of infectious viruses such as Flu and Corona and versatility/safety of 222nm UVC, these data support the powerful preventive strategy against various pathogen. Nevertheless, the manuscript would be further strengthened if the authors can address the following minor concern.

1. In introduction section, author need to clearly clarify the aim of this study why they performed the experiment in liquid and fabric condition, not aerosol and compared the effect in various exposure time, etc. And it also need to be discussed.

Reviewer #2: This manuscript describes the use of Ultraviolet-C light at 222 nm has a high disinfecting spectrum in environments contaminated by infectious pathogens, including SARS-CoV-2 by Song. They examined the effect of 222 nm UV-C irradiation on contaminating bacteria and viruses. A colony forming unit assay was used to determine the number of viable cells, and a virus titration was used as the assay of evaluation. They also found that the irradiation effectively inactivated Delta and Omicron, variants of SARS-CoV-2. These results provide valuable information on the bactericidal efficiency of 222nm UV-C in environments contaminated with bacteria and viruses. The experimental methods, discussion, and argument of the paper are very well done.

Reviewer #3: Authors demonstrated the disinfection efficiency of 222-nm UV-C in bacterial and virus-contaminated environments. Overall, the manuscript was conducted properly and well-written. And the results may provide the valuable information on disinfection. However, the finding lacks the novelty, because the disinfection efficiency of UV-C is already known. The authors did not describe the reason why that they selected 222-nm UV-C in their study. Generally, the disinfection efficiency of 222-nm UV-C is lower than that of 275-nm UV-C. There is no information supporting the safety and advantage of 222-nm UV-C. In virucidal study, the authors only tested enveloped RNA viruses. The authors may need to test other types of viruses such as non-enveloped or DNA viruses.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Nov 28;18(11):e0294427. doi: 10.1371/journal.pone.0294427.r002

Author response to Decision Letter 0


20 Oct 2023

We considered the reviewer's comments favorably and did our best to respond appropriately. I am sending you a "Response to reviewers" file to the editor, so please let me know if there is anything I need to revise.

Attachment

Submitted filename: Response to Reviewers_SK.docx

Decision Letter 1

Yong Sam Jung

31 Oct 2023

Ultraviolet-C light at 222 nm has a high disinfecting spectrum in environments contaminated by infectious pathogens, including SARS-CoV-2

PONE-D-23-28082R1

Dear Dr. Kang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yong Sam Jung, Ph.D.

Academic Editor

PLOS ONE

Acceptance letter

Yong Sam Jung

15 Nov 2023

PONE-D-23-28082R1

Ultraviolet-C light at 222 nm has a high disinfecting spectrum in environments contaminated by infectious pathogens, including SARS-CoV-2

Dear Dr. Kang:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yong Sam Jung

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Survival rate of cell numbers by irradiated UV-C with several optical dosages.

    (PPTX)

    S1 Raw image

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers_SK.docx

    Data Availability Statement

    we provide the original uncropped and unadjusted image and blot results reported in a "original figure raw image" file.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES